Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
A Phase 2, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout and Moderate Renal Impairment
Status: Enrolling
Updated:  11/13/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
A Phase 2, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout and Moderate Renal Impairment
Status: Enrolling
Updated: 11/13/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
A Phase 2, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout and Moderate Renal Impairment
Status: Enrolling
Updated:  11/13/2015
Clinical Research Facility
mi
from
Escondido, CA
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
A Phase 2, Randomized, Double Blind, Multicenter, Placebo Controlled Study to Evaluate the Efficacy and Safety of Febuxostat 40 mg XR, 80 mg XR, 40 mg IR and 80 mg IR in Subjects With Gout and Moderate Renal Impairment
Status: Enrolling
Updated: 11/13/2015
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Status: Enrolling
Updated:  11/16/2015
NYU Hospital for Joint Diseases
mi
from
New York, NY
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
Status: Enrolling
Updated: 11/16/2015
NYU Hospital for Joint Diseases
mi
from
New York, NY
Click here to add this to my saved trials
Losartan for Sickle Cell Kidney Disease
Losartan Treatment for Sickle Cell Chronic Kidney Disease
Status: Enrolling
Updated:  11/16/2015
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Losartan for Sickle Cell Kidney Disease
Losartan Treatment for Sickle Cell Chronic Kidney Disease
Status: Enrolling
Updated: 11/16/2015
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Losartan for Sickle Cell Kidney Disease
Losartan Treatment for Sickle Cell Chronic Kidney Disease
Status: Enrolling
Updated:  11/16/2015
Grady Health Systems
mi
from
Atlanta, GA
Losartan for Sickle Cell Kidney Disease
Losartan Treatment for Sickle Cell Chronic Kidney Disease
Status: Enrolling
Updated: 11/16/2015
Grady Health Systems
mi
from
Atlanta, GA
Click here to add this to my saved trials
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate (STS) for the Treatment Pain With Calcific Uremic Arteriolopathy a Single Armed Extension Phase Prospectively Observe Lesion Progression in the Presence of STS
A Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment
Status: Enrolling
Updated:  11/16/2015
Nephrology Consultants
mi
from
Huntsville, AL
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate (STS) for the Treatment Pain With Calcific Uremic Arteriolopathy a Single Armed Extension Phase Prospectively Observe Lesion Progression in the Presence of STS
A Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment
Status: Enrolling
Updated: 11/16/2015
Nephrology Consultants
mi
from
Huntsville, AL
Click here to add this to my saved trials
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate (STS) for the Treatment Pain With Calcific Uremic Arteriolopathy a Single Armed Extension Phase Prospectively Observe Lesion Progression in the Presence of STS
A Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment
Status: Enrolling
Updated:  11/16/2015
Nephrology Association of Northern Indiana
mi
from
Fort Wayne, IN
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate (STS) for the Treatment Pain With Calcific Uremic Arteriolopathy a Single Armed Extension Phase Prospectively Observe Lesion Progression in the Presence of STS
A Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment
Status: Enrolling
Updated: 11/16/2015
Nephrology Association of Northern Indiana
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate (STS) for the Treatment Pain With Calcific Uremic Arteriolopathy a Single Armed Extension Phase Prospectively Observe Lesion Progression in the Presence of STS
A Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment
Status: Enrolling
Updated:  11/16/2015
A.A. Northeast Clinical Research Center
mi
from
Bethlehem, PA
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate (STS) for the Treatment Pain With Calcific Uremic Arteriolopathy a Single Armed Extension Phase Prospectively Observe Lesion Progression in the Presence of STS
A Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression in the Presence of Sodium Thiosulfate Treatment
Status: Enrolling
Updated: 11/16/2015
A.A. Northeast Clinical Research Center
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated:  11/16/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated: 11/16/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
A Phase 1, 7 Day Repeat Dose, Parallel-Group, Open-Label Study to Evaluate the Safety and Pharmacokinetics of Intravenous Infusion of MTP-131 Administered in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Maimi, FL
A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
A Phase 1, 7 Day Repeat Dose, Parallel-Group, Open-Label Study to Evaluate the Safety and Pharmacokinetics of Intravenous Infusion of MTP-131 Administered in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Maimi, FL
Click here to add this to my saved trials
Evaluation of a Website on Living Kidney Donation for Hispanics
Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Status: Enrolling
Updated:  11/18/2015
University of California Davis
mi
from
Davis, CA
Evaluation of a Website on Living Kidney Donation for Hispanics
Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Status: Enrolling
Updated: 11/18/2015
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Evaluation of a Website on Living Kidney Donation for Hispanics
Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Status: Enrolling
Updated:  11/18/2015
Northwestern Memorial Hospital (NMH)
mi
from
Chicago, IL
Evaluation of a Website on Living Kidney Donation for Hispanics
Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Status: Enrolling
Updated: 11/18/2015
Northwestern Memorial Hospital (NMH)
mi
from
Chicago, IL
Click here to add this to my saved trials
Optimizing Kidney Transplant Informed Consent
Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors
Status: Enrolling
Updated:  11/18/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Optimizing Kidney Transplant Informed Consent
Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors
Status: Enrolling
Updated: 11/18/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Optimizing Kidney Transplant Informed Consent
Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors
Status: Enrolling
Updated:  11/18/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Optimizing Kidney Transplant Informed Consent
Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors
Status: Enrolling
Updated: 11/18/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated:  11/18/2015
Site US00112 American Institute of Research
mi
from
Los Angeles, CA
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Site US00112 American Institute of Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated:  11/18/2015
Site US10003 Orlando Clinical Research Center
mi
from
Orlando, FL
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Site US10003 Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated:  11/18/2015
Site US10001 PAREXEL
mi
from
Baltimore, MD
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Site US10001 PAREXEL
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated:  11/18/2015
Site US10004 Southwest Houston Research
mi
from
Houston, TX
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
A Phase 1, Single-Blind, Parallel-Group, Pharmacokinetic and Immunogenicity Study With ASP0113 in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Status: Enrolling
Updated: 11/18/2015
Site US10004 Southwest Houston Research
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients
Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients
Status: Enrolling
Updated:  12/1/2015
University of Illinois
mi
from
Urbana, IL
Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients
Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients
Status: Enrolling
Updated: 12/1/2015
University of Illinois
mi
from
Urbana, IL
Click here to add this to my saved trials
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
Status: Enrolling
Updated:  12/1/2015
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
Status: Enrolling
Updated: 12/1/2015
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated:  12/2/2015
Clinical Research Facility
mi
from
Lynwood, CA
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated: 12/2/2015
Clinical Research Facility
mi
from
Lynwood, CA
Click here to add this to my saved trials
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated:  12/2/2015
Clinical Research Facility
mi
from
Ontario, CA
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated: 12/2/2015
Clinical Research Facility
mi
from
Ontario, CA
Click here to add this to my saved trials
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated:  12/2/2015
Clinical Research Facility
mi
from
San Dimas, CA
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated: 12/2/2015
Clinical Research Facility
mi
from
San Dimas, CA
Click here to add this to my saved trials
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated:  12/2/2015
mi
from
Gosford,
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
A Randomized, Placebo-controlled, Double-blind, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of 5 Fixed Doses of BAY85-3934 Administered Orally in the Correction of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease Not Currently Treated With Erythropoiesis-stimulating Agent in Europe and Asia Pacific
Status: Enrolling
Updated: 12/2/2015
mi
from
Gosford,
Click here to add this to my saved trials
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated:  12/3/2015
Fresenius Medical Center East Denver
mi
from
Aurora, CO
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated: 12/3/2015
Fresenius Medical Center East Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated:  12/3/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated: 12/3/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated:  12/3/2015
University of Colorado Hospital
mi
from
Aurora, CO
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated: 12/3/2015
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated:  12/3/2015
Fresenius Medical Center Central
mi
from
Denver, CO
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated: 12/3/2015
Fresenius Medical Center Central
mi
from
Denver, CO
Click here to add this to my saved trials
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated:  12/3/2015
Fresenius Medical Center Rocky Mountain
mi
from
Denver, CO
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Estimating and Predicting Hemodynamic Changes During Hemodialysis
Status: Enrolling
Updated: 12/3/2015
Fresenius Medical Center Rocky Mountain
mi
from
Denver, CO
Click here to add this to my saved trials
Protocolized Diuretic Strategy in Cardiorenal Failure
Effect of Protocolized Diuretic Strategy on Clinical Outcomes and Health-related Quality of Life in Cardiorenal Failure: A Randomized Trial
Status: Enrolling
Updated:  12/7/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Protocolized Diuretic Strategy in Cardiorenal Failure
Effect of Protocolized Diuretic Strategy on Clinical Outcomes and Health-related Quality of Life in Cardiorenal Failure: A Randomized Trial
Status: Enrolling
Updated: 12/7/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Bakersfield, CA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Glendale, CA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Torrance, CA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Tampa, FL
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Roswell, GA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Waycross, GA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Waycross, GA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
mi
from
Crestwood, IL
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
mi
from
Crestwood, IL
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Wichita, KA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Shreveport, LA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Boston, MA
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Kalamazoo, MI
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Royal Oak, MI
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Columbia, MO
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
St Louis, MO
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
North Brunswick, NJ
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
North Brunswick, NJ
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
Clinical Research Facility
mi
from
Brooklyn, NY
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated:  12/8/2015
mi
from
Minneola, NY
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Dialysis Patients' Response to IV Iron With Elevated Ferritin
Status: Enrolling
Updated: 12/8/2015
mi
from
Minneola, NY
Click here to add this to my saved trials